FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

MEDPLUS HEALTH SERVICES LTD.

NSE : MEDPLUSBSE : 543427ISIN CODE : INE804L01022Industry : Pharmaceuticals & DrugsHouse : Private

BSE950.9065.2 (+7.36 %)

PREV CLOSE (Rs.) 885.70

OPEN PRICE (Rs.) 880.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 16662

TODAY'S LOW / HIGH (Rs.)875.75 976.20

52 WK LOW / HIGH (Rs.)603 925

NSE952.4564.9 (+7.31 %)

PREV CLOSE( Rs. ) 887.55

OPEN PRICE (Rs.) 881.00

BID PRICE (QTY) 952.45 (18700)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 435203

TODAY'S LOW / HIGH(Rs.) 875.30 980.00

52 WK LOW / HIGH (Rs.)616 925

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

153.42

Dividend Yield(%)

0.00

TTM EPS (Rs.)

3.03

P/E Ratio

313.65

Book Value (Rs.)

102.15

Face Value (Rs.)

MCap (Rs. in Mn)

113816.86

Price/Earning (TTM)

180.28

Price/Sales (TTM)

17.25

Price/Book (MRQ)

9.31

PAT Margin (%)

1.90

ROCE (%)

1.33

Incorporation Year : 30-11 2006

Management Info :

Gangadi Madhukar Reddy - Chairman Gangadi Madhukar Reddy - Managing Director

Registered Office :

Address : H. No: 11-6-56, Survey No: 257 & 258/1,Opp: I D P L Railway Siding Road,Moosapet, Kukatpally,
Hyderabad,
Telangana-500037

Phone : 040-67246724

Email : medplus@medplusindia.com

Website : www.medplusindia.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

04Apr Medplus Health Services informs about
Medplus Health Services has informed that it enclosed revised Disclosure..

25Mar Medplus Health Services submits analys
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Ob..

22Feb Medplus Health Services informs about
Medplus Health Services has informed that Optival Health Solutions, a su..

Financials

	QTR Dec 24	ANNUAL 24
Net Profit	93.6899999999999	95.8099999999992
Gross Profit	120.3	70.4099999999992
Operating Profit	208.83	396.129999999999
Net Sales	1767.93	4670.3

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Emcure Pharma (BSE)

1288.65 (10.00%)

M.Cap (Rs. in Cr)24417.77

Shilpa Medicare (BSE)

781.50 (6.33%)

M.Cap (Rs. in Cr)7642.36

Orchid Pharma (BSE)

754.40 (4.21%)

M.Cap (Rs. in Cr)3826.25

RPG Life Sciences (BSE)

2198.65 (1.36%)

M.Cap (Rs. in Cr)3636.35

Shareholding Pattern

	PROMOTERS	40.34%
	MUTUAL FUNDS/UTI	21.59%
	NON-INSTITUTION	17.86%
	FI/BANKS/INSURANCE	2.26%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

Nippon India Pharma...

3.41

Nippon India Focuse...

2.01

Kotak Small Cap Fund(G)

1.73

Bandhan Innovation ...

1.72

Tata India Innovati...

1.57

Franklin India Smal...

1.54

ICICI Pru Pharma He...

1.54

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

MEDPLUS HEALTH SERVICES LTD.

Smart Quotes

Attention Investors

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Filing complaints on SCORESEasy & quick

Risk Disclosures On Derivatives